Gregory Oakes
2022
In 2022, Gregory Oakes earned a total compensation of $1.8M as Chief Executive Officer and Director at Landos Biopharma.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $324,900 |
| Option Awards | $956,872 |
| Salary | $320,769 |
| Other | $11,089 |
| Total | $1,763,630 |
Oakes received $956.9K in option awards, accounting for 54% of the total pay in 2022.
Oakes also received $150K in bonus, $324.9K in non-equity incentive plan, $320.8K in salary and $11.1K in other compensation.
Rankings
In 2022, Gregory Oakes' compensation ranked 1,955th out of 5,736 executives tracked by ExecPay. In other words, Oakes earned more than 65.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,955 out of 5,736 | 66th |
Division Manufacturing | 1,043 out of 3,125 | 67th |
Major group Chemicals And Allied Products | 441 out of 1,416 | 69th |
Industry group Drugs | 404 out of 1,317 | 69th |
Industry Pharmaceutical Preparations | 292 out of 963 | 70th |
Source: SEC filing on April 19, 2023.
Oakes' colleagues
We found four more compensation records of executives who worked with Gregory Oakes at Landos Biopharma in 2022.